Resultados de la búsqueda 931-940 of 15021 for effets à long terme du Doliprane

  1. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate the safety [including dose-limiting toxicities (DLTs)] of the combination therapy of TILT-123 and pembrolizumab in ...

  2. Oncología (médica) - Ensayos clínicos

    Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

  4. Oncología (médica) - Ensayos clínicos

    The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the registry will be to support ongoing ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

  6. Mayo Clinic

    Share · Tweet . VID-20193984. Inicio; Genetic Bone Diseases in Children. Tu donación es muy poderosa... ¿quieres hacerla hoy mismo?

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy. A ...

  8. Mayo Clinic

    Tuve apendicitis aguda y tuvieron que extirparme el apéndice y pienso que todo está bien. Creo que estoy en camino a estar sano y que volvería a mi vida normal.

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

  10. Oncología (médica) - Ensayos clínicos

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that has ...